| Radiology, Nuclear Medicine and Imaging | Lifetime | 363 | DE 22 | 99.12 |
| Ophthalmology | Lifetime | 128 | DE 3 | 99.26 |
| Public, Environmental and Occupational Health | Lifetime | 877 | DE 15 | 98.74 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 55 | DE 4 | 99.05 |
| Ophthalmology | 2021-2025 | 23 | DE 1 | 99.30 |
| Public, Environmental and Occupational Health | 2021-2025 | 311 | DE 5 | 97.33 |
| Epidemiology | 2021-2025 | 741 | DE 27 | 92.76 |
| Clinical Neurology | 2021-2025 | 716 | DE 43 | 43.55 |
| Corneal surgery and disorders | Lifetime | 48 | DE 4 | 99.60 |
| Corneal Surgery and Treatments | Lifetime | 46 | DE 3 | 99.36 |
| Ocular Surface and Contact Lens | Lifetime | 64 | DE 4 | 99.29 |
| Intraocular Surgery and Lenses | Lifetime | 76 | DE 5 | 99.39 |
| Glaucoma and retinal disorders | Lifetime | 161 | DE 10 | 99.39 |
| Ocular Infections and Treatments | Lifetime | 46 | DE 2 | 99.09 |
| Ophthalmology and Visual Impairment Studies | Lifetime | 109 | DE 5 | 99.01 |
| Ocular Oncology and Treatments | Lifetime | 582 | DE 43 | 92.71 |
| Ocular Disorders and Treatments | Lifetime | 237 | DE 10 | 92.26 |
| Medical and Health Sciences Research | Lifetime | 676 | DE 513 | 84.83 |
| Organ and Tissue Transplantation Research | Lifetime | 808 | DE 44 | 87.41 |
| Drug-Induced Ocular Toxicity | Lifetime | 293 | DE 10 | 84.16 |
| Medical and Biological Ozone Research | Lifetime | 774 | DE 36 | 81.21 |
| Legionella and Acanthamoeba research | Lifetime | 885 | DE 39 | 82.86 |
| Ophthalmology and Visual Health Research | Lifetime | 844 | DE 8 | 74.24 |
| Hallucinations in medical conditions | Lifetime | 746 | DE 44 | 36.55 |
| Corneal Surgery and Treatments | 2021-2025 | 4 | DE 1 | 99.34 |
| Corneal surgery and disorders | 2021-2025 | 9 | DE 2 | 99.51 |
| Ocular Surface and Contact Lens | 2021-2025 | 21 | DE 1 | 98.82 |
| Ocular Infections and Treatments | 2021-2025 | 11 | DE 1 | 98.06 |
| Glaucoma and retinal disorders | 2021-2025 | 80 | DE 4 | 98.82 |
| Retinal and Optic Conditions | 2021-2025 | 160 | DE 2 | 96.22 |
| Ophthalmology and Visual Impairment Studies | 2021-2025 | 204 | DE 17 | 94.17 |
| Retinal Diseases and Treatments | 2021-2025 | 545 | DE 21 | 94.86 |
| Intraocular Surgery and Lenses | 2021-2025 | 231 | DE 22 | 93.01 |
| Ocular Diseases and Behçet’s Syndrome | 2021-2025 | 208 | DE 6 | 92.33 |
| Retinal Imaging and Analysis | 2021-2025 | 556 | DE 9 | 92.04 |
| Medical and Health Sciences Research | 2021-2025 | 79 | DE 66 | 78.88 |
| Ocular Oncology and Treatments | 2021-2025 | 334 | DE 37 | 80.30 |
| Ophthalmology and Visual Health Research | 2021-2025 | 170 | DE 2 | 69.02 |
| Retinal and Macular Surgery | 2021-2025 | 916 | DE 65 | 69.69 |
| Developmental Biology and Gene Regulation | 2021-2025 | 351 | DE 19 | 57.51 |
| Medical and Biological Ozone Research | 2021-2025 | 639 | DE 11 | 45.40 |
| Hallucinations in medical conditions | 2021-2025 | 64 | DE 7 | 41.45 |
| Drug-Induced Ocular Toxicity | 2021-2025 | 219 | DE 6 | 42.79 |
| Legionella and Acanthamoeba research | 2021-2025 | 800 | DE 34 | 34.80 |
| Planarian Biology and Electrostimulation | 2021-2025 | 851 | DE 49 | 20.77 |
